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This issue of the journal sees a diverse group of manu-
scripts that takes us through to the end of 2008 and of
our 15th year of publication—an appropriate time to
thank all our sponsors and supporters for their contri-
butions and our editorial board and support staff for
their many hours of effort.
In the area of clinical practice, Dr. Zeina Nahleh
and colleagues provide an interesting review and
analysis of outcomes for neoadjuvant chemotherapy
in locally advanced breast cancer—including the in-
flammatory form—and of subsequent disease-free
and overall survival. Dr. Barbara Melosky and co-
authors report their experience with the use of sec-
ond-line erlotinib following failure of first-line
platinum-based chemotherapy, suggesting that this
epidermal growth factor receptor–tyrosine kinase
receptor inhibitor may be an efficacious and well-
tolerated option for some patients. From the National
Cancer Institute of Canada comes a report of a large
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prospective study designed to test the benefits of
physical activity on well-being and survival in pa-
tients with stages II and III colon cancer following
adjuvant chemotherapy. From McGill, Dr. Hamdy
Elhateer and colleagues describe their experience in
the management of pituitary macroadenomas, report-
ing an impressive 100% control rate after a median
of 2 years of follow-up. My personal thanks go to
Dr. Susan Solymoss for her scholarly editorial re-
view of current substantial changes in the manage-
ment of thrombosis in cancer patients.
A new educational series—Drug Developments in
Contemporary Oncology—is introduced in this issue,
and we are grateful to Drs. Matthew Warr and Gordon
Shore for their introductory manuscript on small-mol-
ecule Bcl-2 antagonists as targeted therapy. This se-
ries will run throughout 2009.
Finally, on behalf of the team, compliments of the
season to all of our readership!